JPS6157316B2 - - Google Patents

Info

Publication number
JPS6157316B2
JPS6157316B2 JP60024567A JP2456785A JPS6157316B2 JP S6157316 B2 JPS6157316 B2 JP S6157316B2 JP 60024567 A JP60024567 A JP 60024567A JP 2456785 A JP2456785 A JP 2456785A JP S6157316 B2 JPS6157316 B2 JP S6157316B2
Authority
JP
Japan
Prior art keywords
acid
solution
formula
mixture
mercaptotetrazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP60024567A
Other languages
English (en)
Japanese (ja)
Other versions
JPS60185788A (ja
Inventor
Jei Gotsutosutein Uiriamu
Ei Kapuran Muurei
Pii Guranatetsuku Arufuonsu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/590,971 external-priority patent/US4297489A/en
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of JPS60185788A publication Critical patent/JPS60185788A/ja
Publication of JPS6157316B2 publication Critical patent/JPS6157316B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP60024567A 1975-06-27 1985-02-13 抗菌剤 Granted JPS60185788A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/590,971 US4297489A (en) 1974-09-03 1975-06-27 7-α-Amino-substituted acylamino-3-(1-carboxymethyltetrazol-5-ylthiomethyl)-3-cephem-4-carboxylic acids
US590971 1975-06-27

Publications (2)

Publication Number Publication Date
JPS60185788A JPS60185788A (ja) 1985-09-21
JPS6157316B2 true JPS6157316B2 (US20080094685A1-20080424-C00004.png) 1986-12-06

Family

ID=24364483

Family Applications (2)

Application Number Title Priority Date Filing Date
JP51000565A Granted JPS525787A (en) 1975-06-27 1976-01-01 Antiibacterial agent
JP60024567A Granted JPS60185788A (ja) 1975-06-27 1985-02-13 抗菌剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP51000565A Granted JPS525787A (en) 1975-06-27 1976-01-01 Antiibacterial agent

Country Status (4)

Country Link
US (1) US4100346A (US20080094685A1-20080424-C00004.png)
JP (2) JPS525787A (US20080094685A1-20080424-C00004.png)
IL (1) IL61566A0 (US20080094685A1-20080424-C00004.png)
SU (1) SU867310A3 (US20080094685A1-20080424-C00004.png)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4297489A (en) * 1974-09-03 1981-10-27 Bristol-Myers Company 7-α-Amino-substituted acylamino-3-(1-carboxymethyltetrazol-5-ylthiomethyl)-3-cephem-4-carboxylic acids
US4286089A (en) * 1974-12-27 1981-08-25 Smithkline Corporation 7-Acyl-3-(substituted tetrazolyl thiomethyl)cephalosporins
US4220644A (en) * 1976-05-03 1980-09-02 Smithkline Corporation 7-Acylamino-3-(substituted tetrazolyl thiomethyl) cephalosporins
US4189573A (en) * 1976-11-02 1980-02-19 Smithkline Corporation 7-Amino-3-(phosphonoalkyl and esterified phosphonoalkyl substituted tetrazolylthiomethyl)cephalosporins
FR2387235A1 (fr) * 1978-01-23 1978-11-10 Fujisawa Pharmaceutical Co Procede de preparation de composes d'acide 3,7-disubstitue-3-cephem-4-carboxylique et nouveaux produits ainsi obtenus, ayant une forte activite antibacterienne
DK225179A (da) * 1978-06-22 1979-12-23 Chugai Pharmaceutical Co Ltd Fremgangsmaade til fremstilling af cephalosporinderivater
US4223135A (en) * 1979-03-19 1980-09-16 Bristol-Myers Company Production of cephalosporins
US4316017A (en) * 1979-03-19 1982-02-16 Bristol-Myers Company Cephalosporin intermediates
US4316016A (en) * 1979-03-19 1982-02-16 Bristol-Myers Company Cephalosporin intermediates
US4243803A (en) * 1979-07-05 1981-01-06 Bristol-Myers Company Production of 7-(2-aminomethylphenylacetamido)-3-(1-carboxymethyltetrazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid
US4420477A (en) * 1979-11-30 1983-12-13 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US4346076A (en) * 1980-09-17 1982-08-24 Eli Lilly And Company Bis-tetrazoylmethyl substituted cephalosporin antibiotics
US4448958A (en) * 1982-10-20 1984-05-15 Bristol-Myers Company Purification of ceforanide
KR20070036088A (ko) * 2004-06-30 2007-04-02 디에스엠 아이피 어셋츠 비.브이. 베타-락탐 항생제를 포함하는 생성물
WO2008010043A2 (en) * 2006-07-18 2008-01-24 Orchid Chemicals & Pharmaceuticals Limited Improved process for the preparation of ceforanide in pure form
CN102898442A (zh) * 2012-10-25 2013-01-30 河南中帅医药科技发展有限公司 头孢雷特的精制方法
US10626156B2 (en) * 2013-12-06 2020-04-21 Jie Han Bioreversable promoieties for nitrogen-containing and hydroxyl-containing drugs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3819623A (en) * 1968-04-12 1974-06-25 Fujisawa Pharmaceutical Co 3,7-disubstituted cephalosporin compounds

Also Published As

Publication number Publication date
JPS525787A (en) 1977-01-17
JPS60185788A (ja) 1985-09-21
JPS6150957B2 (US20080094685A1-20080424-C00004.png) 1986-11-06
US4100346A (en) 1978-07-11
SU867310A3 (ru) 1981-09-23
IL61566A0 (en) 1980-12-31

Similar Documents

Publication Publication Date Title
FI66618B (fi) Foerfarande foer framstaellning av terapeutiskt verkande 7-(2-(2-aminotiazol-4-yl)-2-(syn)-metoxi-iminoacetamido)-cefalosporinderivat
JPS6157316B2 (US20080094685A1-20080424-C00004.png)
US4065620A (en) 3-(Substituted) vinyl cephalosporins
JPS6153359B2 (US20080094685A1-20080424-C00004.png)
FI93458C (fi) Menetelmä terapeuttisesti käyttökelpoisen 7-/2-(2-aminotiatsol-4-yyli)-2-(Z)-hydroksi-iminoasetamido/-3-(metoksimetyyli)-3-kefeemi-4-karboksyylihappo-/ -(2,2-dimetyylipropionyylioksi)etyyli/esterin diastereomeerin I valmistamiseksi
US4297489A (en) 7-α-Amino-substituted acylamino-3-(1-carboxymethyltetrazol-5-ylthiomethyl)-3-cephem-4-carboxylic acids
JPS597717B2 (ja) セフアロスポリン誘導体およびその製造法
JP2867192B2 (ja) 7−アシル−3−置換カルバモイルオキシセフェム化合物及びその製造法
US4104469A (en) 7-(Syn-α-alkoxy-iminofuryl)acetamido-3-(2-methyl-2,3-dihydro-s-triazolo[4,3-b]pyridazin-3-on-6-ylthiomethyl)-3-cephem-4-carboxylic acids
SU576948A3 (ru) Способ получени производных цефалоспорановой кислоты или их солей
JPS6133836B2 (US20080094685A1-20080424-C00004.png)
US4103085A (en) 7-(Syn-α-alkoxy-iminofurylacetamido-3-(2-carboxyalkyl-2,3-dihydro-s-triazolo[4,3-b]pyridazin-3-on-6-ylthiomethyl)-3-cephem-4-carboxylic acids
JPS60222489A (ja) 7−アミノセフエム化合物の製法
US4151352A (en) 7-Amino-3-(2-carboxyalkyl-2,3-dihydro-s-triazolo[4,3-b]pyridazin-3-on-6-ylthiomethyl)-3-cephem-4-carboxylic acids
US4182863A (en) 7-Amino-3-(1-carboxymethyltetrazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid
JPH0521912B2 (US20080094685A1-20080424-C00004.png)
US4172196A (en) Certain 7-α-substituted-α-hydroxyacetamido-3-(1-carboxymethyltetrazol-5-yl-thiomethyl)-3-cephem-4-carboxylic acids
JPS6026800B2 (ja) 新規な7α−メトキシセフアロスポリン類およびその製造法
US4835150A (en) Cephem compounds
JPS59152385A (ja) ヒドロキサム酸系セフアロスポリン誘導体
US3910900A (en) 7-(D-a-hydroxy-2-arylacetamido)-3-(3-hydroxypyridazin-6-ylthiomethyl)-3-cephem-4-carboxylic acids
CA1041087A (en) SUBSTITUTED .alpha.-CARBOXY ACETAMIDOCEPHALOSPORINS
US4180658A (en) 7[-2-Alkoxyamino(acetamido)]cephalosporin derivatives
CA1113455A (en) 7-acylamido-3-(2-carboxyalkyl-2,3-dihydro-3-triazolo ¬4,3-b| pyridazin-3-on-6-ylthiomethyl)-3-cephem- 4-carboxylic acids
US3985738A (en) 7-(D-.alpha.-Hydroxy-2-arylacetamido)-3-(tetrazolo-[4,5-b]pyridazin-6-ylthiomethyl)-3-cephem-4-carboxylic acids